Perrigo Company plc Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)
Perrigo Company plc (PRGO) reported Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss) of $9.40 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-05-22.
Discontinued › Notes › Compensation Related Costs › Retirement Benefits › Defined Benefit Plan › Defined Benefit Plan, Roll Forwards
us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets · last filed 2017-05-22
- Perrigo Company plc defined benefit plan, plan assets, increase (decrease) for actual return (loss) for fiscal 2016 was $9.40M.
- Perrigo Company plc defined benefit plan, plan assets, increase (decrease) for actual return (loss) for fiscal 2015 was -$1.00M.
| Period end | Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss) 6 month | Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss) 6 month as first filed | Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss) 12 month |
|---|---|---|---|
| 2016-12-31 | $9.40M 10-K · filed 2017-05-22 | ||
| 2015-12-31 | -$1.70M 10-K · filed 2017-05-22 | -$600.00K 10-KT · filed 2016-02-25 | |
| 2015-06-27 | -$1.00M 10-KT · filed 2016-02-25 | ||
| 2014-06-28 | $5.40M 10-K · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |